The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma
Developmental Cell2022Vol. 57(10), pp. 1226–1240.e8
Citations Over TimeTop 10% of 2022 papers
Anand G. Patel, Xiang Chen, Xin Huang, Michael R. Clay, Natalia L. Komarova, Matthew J. Krasin, Alberto S. Pappo, Heather Tillman, Brent A. Orr, Justina McEvoy, Brittney Gordon, Kaley Blankenship, Colleen Reilly, Xin Zhou, Jacqueline L. Norrie, Åsa Karlström, Jiyang Yu, Dominik Wodarz, Elizabeth Stewart, Michael A. Dyer
Related Papers
- → Pax3 functions in cell survival and in pax7 regulation(1999)175 cited
- → In vitro indeterminate teleost myogenesis appears to be dependent on Pax3(2013)57 cited
- → Functional Dissection of Pax3 in Paraxial Mesoderm Development and Myogenesis(2012)32 cited
- → Decoding the ‘embryonic’ nature of embryonal rhabdomyosarcoma(2015)3 cited
- The Role of microRNA in Myogenesis and Rhabdomyosarcoma(2014)